Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Novan Inc (NOVN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,793
  • Shares Outstanding, K 26,057
  • Annual Sales, $ 2,140 K
  • Annual Income, $ -37,130 K
  • 36-Month Beta 3.21
  • Price/Sales 12.56
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.31
  • Number of Estimates 2
  • High Estimate -0.30
  • Low Estimate -0.32
  • Prior Year -0.51
  • Growth Rate Est. (year over year) +39.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.18 unch
on 02/15/19
1.69 -30.18%
on 01/16/19
-0.11 (-8.53%)
since 01/15/19
3-Month
0.65 +81.54%
on 12/27/18
2.45 -51.84%
on 11/19/18
-1.24 (-51.24%)
since 11/15/18
52-Week
0.65 +81.54%
on 12/27/18
3.49 -66.19%
on 03/12/18
-2.25 (-65.60%)
since 02/15/18

Most Recent Stories

More News
Is WisdomTree International High Dividend Fund (DTH) a Strong ETF Right Now?

Smart Beta ETF report for DTH

EFA : 63.62 (+1.45%)
IEFA : 59.57 (+1.45%)
DTH : 39.88 (+1.22%)
NOVN : 1.18 (-3.28%)
Novan Announces Management Changes and Provides Business Update

-- Paula Brown Stafford promoted to President and newly created role of Chief Operating Officer of Novan

NOVN : 1.18 (-3.28%)
Is WisdomTree International High Dividend Fund (DTH) a Strong ETF Right Now?

Smart Beta ETF report for DTH

EFA : 63.62 (+1.45%)
IEFA : 59.57 (+1.45%)
DTH : 39.88 (+1.22%)
NOVN : 1.18 (-3.28%)
Notification of a New Drug Application for HP-3070 (Transdermal Patch for the Treatment of Schizophrenia) in the U.S.

Hisamitsu Pharmaceutical Co., Ltd. (Headquarters: Tosu City, Saga Prefecture, President and Chief Executive Officer (CEO): Hirotaka Nakatomi, hereinafter "Hisamitsu Pharmaceutical"), in conjunction...

HTSUF : 84.5500 (unch)
NOVN : 1.18 (-3.28%)
Novan Announces Top-Line Data From Mid-Stage Molluscum Study

Novan's (NOVN) nitric oxide candidate, SB206, demonstrates statistically significant reduction of lesions in patients with molluscum contagiosum.

BLCM : 3.17 (+0.96%)
GLMD : 7.68 (+2.81%)
NOVN : 1.18 (-3.28%)
BSTC : 71.62 (+5.35%)
Novan to Present Data from SB414 Phase 1b Atopic Dermatitis Clinical Trial at 3rd Inflammatory Skin Disease Summit

Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that clinical results from the Company's Phase 1b trial with SB414 cream for the treatment of atopic dermatitis will be presented at...

NOVN : 1.18 (-3.28%)
Novan Announces Full Top Line Results from Phase 2 Molluscum Contagiosum Clinical Trial and Decision to Move Forward with SB206 12% Once-Daily

-- Statistically significant reductions in molluscum lesions as early as Week 2 with 12% once-daily

NOVN : 1.18 (-3.28%)
Is WisdomTree International High Dividend Fund (DTH) a Hot ETF Right Now?

Smart Beta ETF report for DTH

EFA : 63.62 (+1.45%)
IEFA : 59.57 (+1.45%)
DTH : 39.88 (+1.22%)
NOVN : 1.18 (-3.28%)
Novan to Present at Piper Jaffray 30th Annual Healthcare Conference

Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that Paula Brown Stafford, Chief Development Officer, and Nathan Stasko, President and Chief Scientific Officer, are scheduled to participate...

NOVN : 1.18 (-3.28%)
Consolidated Research: 2018 Summary Expectations for Moleculin Biotech, Novan, PAVmed, Maui Land & Pineapple, Hallmark Financial Services, and McEwen Mining -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Moleculin Biotech, Inc....

MLP : 12.20 (+1.16%)
MUX : 1.88 (+5.03%)
HALL : 10.26 (+2.09%)
NOVN : 1.18 (-3.28%)
PAVM : 0.98 (unch)
MBRX : 1.47 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade NOVN with:

Business Summary

Novan, Inc. is a pharmaceutical company. It engaged in the development and commercialization of therapies using its nitric oxide platform for dermatology. The Company's product candidates primarily include SB204, SB206, SB208 and SB414 which are in pre-clinical trial stage. It develops product through...

See More

Key Turning Points

2nd Resistance Point 1.23
1st Resistance Point 1.21
Last Price 1.18
1st Support Level 1.17
2nd Support Level 1.15

See More

52-Week High 3.49
Fibonacci 61.8% 2.41
Fibonacci 50% 2.07
Fibonacci 38.2% 1.73
Last Price 1.18
52-Week Low 0.65

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar